{
    "organizations": [],
    "uuid": "8d4f66ee798a1b2c9e9afccede3963782cc8b8e8",
    "author": "",
    "url": "https://www.reuters.com/article/brief-icer-says-spark-therapeutics-gene/brief-icer-says-spark-therapeutics-gene-therapy-price-too-high-idUSL1N1P717V",
    "ord_in_thread": 0,
    "title": "BRIEF-ICER Says Spark Therapeutics Gene Therapy Price Too High",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "January 12, 2018 / 4:58 PM / Updated 6 minutes ago BRIEF-ICER Says Spark Therapeutics Gene Therapy Price Too High Reuters Staff 1 Min Read \nJan 12 (Reuters) - Spark Therapeutics Inc: \n* INSTITUTE FOR CLINICAL AND ECONOMIC REVIEW SAYS SPARK THERAPEUTICS LUXTURNA GENE THERAPY PRICE FAR TOO HIGH \n* ICER SAYS $850,000 PRICE FOR LUXTURNA BLINDNESS TREATMENT SHOULD BE 75-82 PERCENT LOWER BASED ON VALUE ASSESSMENT \n* ICER RECOMMENDS LUXTURNA PRICE BETWEEN $153,000 AND $217,000 FOR ONE-TIME GENE THERAPY Source text for Eikon: Further company coverage: (Reporting By Bill Berkrot)",
    "published": "2018-01-12T18:57:00.000+02:00",
    "crawled": "2018-01-12T19:15:09.022+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "january",
        "pm",
        "updated",
        "minute",
        "ago",
        "say",
        "spark",
        "therapeutic",
        "gene",
        "therapy",
        "price",
        "high",
        "reuters",
        "staff",
        "min",
        "read",
        "jan",
        "reuters",
        "spark",
        "therapeutic",
        "inc",
        "institute",
        "clinical",
        "economic",
        "review",
        "say",
        "spark",
        "therapeutic",
        "luxturna",
        "gene",
        "therapy",
        "price",
        "far",
        "high",
        "icer",
        "say",
        "price",
        "luxturna",
        "blindness",
        "treatment",
        "percent",
        "lower",
        "based",
        "value",
        "assessment",
        "icer",
        "recommends",
        "luxturna",
        "price",
        "gene",
        "therapy",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "reporting",
        "bill",
        "berkrot"
    ]
}